Complement Activation and Key Risk Factors in Disease Assessment for IgAN
Complement Activation and Key Risk Factors in Disease Assessment for IgAN is organized by Prime Education, LLC.
Release Date: September 5, 2023
Expiration Date: September 4, 2024
Description:
Immunoglobin A nephropathy (IgAN) patients often experience delays in diagnosis, limiting their access to essential treatment needed to slow disease progression.
Test your knowledge of the underlying pathogenesis of IgAN and recognize the key risk factors in patients. See how your score stacks up against other healthcare professionals in this interactive quiz.
Learning Objectives:
• Describe the role of complement pathway activation in the pathogenesis and clinical presentation of IgAN
• Use guideline-recommended screening and diagnostic evaluation for IgAN
• Apply the latest clinical evidence for risk stratification and monitoring disease progression in IgAN
Agenda:
• Complement Activation as a Driver of IgAN Pathogenesis
• Key Factors in IgAN Risk Assessment